Skip to content

Clinical trials

Phase 1/2 Leukemia, Myeloid, Acute trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1/2 Country / region: United Kingdom Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20113
20121
20132
20143
20151
20162
20181
20193
20204
20213
20222
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated7
Recruiting6
Active, not recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Celgene2
Cell Medica Ltd2
Akinion Pharmaceuticals AB1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
BeOne Medicines1
Bellicum Pharmaceuticals1
Cardiff University1
CellCentric Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute30
Myelodysplastic Syndromes13
Leukemia7
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Recurrence5
Hematologic Neoplasms4
Neoplasms4
Leukemia, Myelomonocytic, Chronic3
Multiple Myeloma3
Lymphoma, Non-Hodgkin2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.